Canada markets close in 1 hour 16 minutes

Laboratorios Farmaceuticos Rovi, S.A. (41L.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
90.30+2.10 (+2.38%)
As of 02:56PM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
779,054
829,509
817,698
648,677
419,961
Cost of Revenue
327,120
337,224
298,085
263,855
178,652
Gross Profit
451,934
492,285
519,613
384,822
241,309
Operating Expenses
Selling General and Administrative
-
37,977
32,775
12,713
11,409
Total Operating Expenses
273,118
272,031
263,763
203,335
163,880
Operating Income or Loss
178,816
220,254
255,850
181,487
77,429
Interest Expense
836
667
606
669
806
Income Before Tax
178,249
220,408
257,967
182,628
72,581
Income Tax Expense
40,448
50,109
58,302
29,551
11,524
Income from Continuing Operations
137,801
170,299
199,665
153,077
61,057
Net Income
137,837
170,335
199,669
153,077
61,057
Net Income available to common shareholders
137,837
170,335
199,669
153,077
61,057
Basic EPS
3.73
3.29
3.73
2.76
1.10
Diluted EPS
3.73
3.29
3.73
2.76
1.10
Basic Average Shares
53,466
51,820
53,466
55,404
55,386
Diluted Average Shares
53,466
51,820
53,466
55,404
55,386